Back to Agenda
Session 5 Track A: Transparency and Openness
Session Chair(s)
Vratislav Hadrava, MD, PhD
Vice President and Medical Director, Global Innovative Products
Pfizer Canada, Inc., Canada
The session will review the pre-market transparency initiatives underway within the Health Products and Food Branch, provide update and next steps as well as the evolution of the post-market clinical data transparency within industry, the different models of data sharing initiatives and industry endorsement of data sharing principles.
Learning Objective : At the conclusion of the session, participants should be able to: • Define the pre-market transparency initiatives underway within the Health Products and Food Branch • Understand the progression of the initiatives since their inception • Identify possibilities for future expansion of the transparency initiatives
Speaker(s)
Speaker
Jessica S. Scott, JD, MD
Legacy Health Strategies , United States
President
![Laura Johnson](/_Images/member/Generic_Image_Missing-Profile.jpg)
Update on Premarket Transparency in the Health Products and Food Branch, Health Canada
Laura Johnson
Health Canada, Canada
Project Manager
![Rebecca Bose](/_Images/member/Generic_Image_Missing-Profile.jpg)
Speaker
Rebecca Bose
Health Canada, Canada
Policy Division-Policy Science Int'l Programs, Therapeutic Products Directorate
Speaker
Sandra A. Morris, PhD, PMP
Johnson & Johnson, United States
Vice President, Strategy Realization
Speaker
Marla Jo Brickman, PhD
Pfizer Inc, United States
Senior Director - Clinical Data Transparency/Compassionate Access Lead
Have an account?